Cipla is currently trading at Rs. 1325.05, up by 12.40 points or 0.94% from its previous closing of Rs. 1312.65 on the BSE.

The scrip opened at Rs. 1311.05 and has touched a high and low of Rs. 1330.50 and Rs. 1311.05 respectively. So far 6768 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1672.20 on 23-Oct-2025 and a 52 week low of Rs. 1283.00 on 27-Jan-2026.

Last one week high and low of the scrip stood at Rs. 1354.15 and Rs. 1301.00 respectively. The current market cap of the company is Rs. 106889.58 crore.

The promoters holding in the company stood at 29.21%, while Institutions and Non-Institutions held 54.64% and 16.14% respectively.

Cipla’s wholly owned subsidiary -- Cipla (EU), UK, has incorporated a new wholly owned subsidiary named ‘Cipla Middle East Company’ in the Kingdom of Saudi Arabia, effective March 1, 2026. Cipla Middle East Company has been incorporated with the objective of establishing a legal entity for manufacturing and distribution of pharmaceutical products and hold marketing authorisations in KSA. 

Cipla is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).